Experiences With Automated Surgical Drainage in Cardiac Surgery
NCT03860363 is an observational study sponsored by Centese, Inc.. As of 21 Nov 2026, it is completed. It studies Hemorrhage. The registry lists an enrollment of 28 participants at 1 site in 1 country. The registry lists a start date of 22 Feb 2019 and a primary completion date of 30 Mar 2020.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT03860363 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Centese, Inc. |
| Enrollment | 28 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Hemorrhage |
| Start | 22 Feb 2019 |
| Primary completion | 30 Mar 2020 |
| Study completion | 30 May 2020 |
| Last update posted | 17 Jul 2020 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jack Boyd, MD
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Stanford
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT03860363
Each answer restates registry values shown on this page.
What is NCT03860363?
NCT03860363 is an observational study sponsored by Centese, Inc.. It studies Hemorrhage.
Who leads NCT03860363?
The registry names Jack Boyd, MD (principal investigator, Stanford University) as the overall official.
Where does NCT03860363 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT03860363 end?
The registry lists a primary completion date of 30 Mar 2020 and a study completion date of 30 May 2020. The sponsor last updated the record on 17 Jul 2020.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.